Familial monophasic acute transverse myelitis due to the pathogenic variant in VPS37A

Maureen A. Mealy, Tai Seung Nam, Santiago J. Pardo, Carlos A Pardo-Villamizar, Nara Sobreira, Dimitrios Avramopoulos, David Valle, Kathleen Burns, Michael Levy

Research output: Contribution to journalArticle

Abstract

Objective: To identify genetic differences among siblings with a family history of idiopathic transverse myelitis (ITM). Methods: We compared whole-exome sequencing (WES) on germline samples from the 2 affected sisters with ITM with 3 of their healthy siblings. Results: The 2 sisters with ITM both had acute onset of sensory loss in the legs, weakness, and bowel/bladder dysfunction. The first developed ITM at age 15 years with a clinical nadir of complete paralysis, which slowly recovered over a few years. MRI demonstrated a persistent T2 lesion in the lower thoracic cord. The second developed ITM at age 50 years with a nadir of sensory loss from T6 down and paraparesis in the legs, associated with an MRI lesion at T6. She also made a partial recovery with treatment. Both sisters are homozygous for a missense variant in VPS37A (c.700C>A, p.Leu234Ile) identified by WES. We performed targeted sequencing of VPS37A in an additional 86 samples from patients with ITM and 175 with other diseases to investigate the p.Leu234Ile variant. We identified another patient with ITM homozygous for the same rare variant. No patients with multiple sclerosis, neuromyelitis optica, other neurologic conditions, or any healthy controls in public databases were homozygous for this variant. Conclusions: A rare missense variant in VPS37A may predispose to development of ITM. Further studies are necessary to determine the frequency of this variant in the patient population and the mechanism through which it contributes to the risk of disease.

Original languageEnglish (US)
Article numbere213
JournalNeurology: Genetics
Volume4
Issue number1
DOIs
StatePublished - Feb 1 2018

Fingerprint

Transverse Myelitis
Siblings
Exome
Leg
Neuromyelitis Optica
Paraparesis
Paralysis
Nervous System
Multiple Sclerosis
Spinal Cord
Urinary Bladder
Databases

ASJC Scopus subject areas

  • Clinical Neurology
  • Genetics(clinical)

Cite this

Familial monophasic acute transverse myelitis due to the pathogenic variant in VPS37A. / Mealy, Maureen A.; Nam, Tai Seung; Pardo, Santiago J.; Pardo-Villamizar, Carlos A; Sobreira, Nara; Avramopoulos, Dimitrios; Valle, David; Burns, Kathleen; Levy, Michael.

In: Neurology: Genetics, Vol. 4, No. 1, e213, 01.02.2018.

Research output: Contribution to journalArticle

@article{00cc60fd49064e1f9f38a3393827b889,
title = "Familial monophasic acute transverse myelitis due to the pathogenic variant in VPS37A",
abstract = "Objective: To identify genetic differences among siblings with a family history of idiopathic transverse myelitis (ITM). Methods: We compared whole-exome sequencing (WES) on germline samples from the 2 affected sisters with ITM with 3 of their healthy siblings. Results: The 2 sisters with ITM both had acute onset of sensory loss in the legs, weakness, and bowel/bladder dysfunction. The first developed ITM at age 15 years with a clinical nadir of complete paralysis, which slowly recovered over a few years. MRI demonstrated a persistent T2 lesion in the lower thoracic cord. The second developed ITM at age 50 years with a nadir of sensory loss from T6 down and paraparesis in the legs, associated with an MRI lesion at T6. She also made a partial recovery with treatment. Both sisters are homozygous for a missense variant in VPS37A (c.700C>A, p.Leu234Ile) identified by WES. We performed targeted sequencing of VPS37A in an additional 86 samples from patients with ITM and 175 with other diseases to investigate the p.Leu234Ile variant. We identified another patient with ITM homozygous for the same rare variant. No patients with multiple sclerosis, neuromyelitis optica, other neurologic conditions, or any healthy controls in public databases were homozygous for this variant. Conclusions: A rare missense variant in VPS37A may predispose to development of ITM. Further studies are necessary to determine the frequency of this variant in the patient population and the mechanism through which it contributes to the risk of disease.",
author = "Mealy, {Maureen A.} and Nam, {Tai Seung} and Pardo, {Santiago J.} and Pardo-Villamizar, {Carlos A} and Nara Sobreira and Dimitrios Avramopoulos and David Valle and Kathleen Burns and Michael Levy",
year = "2018",
month = "2",
day = "1",
doi = "10.1212/NXG.0000000000000213",
language = "English (US)",
volume = "4",
journal = "Neurology: Genetics",
issn = "2376-7839",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Familial monophasic acute transverse myelitis due to the pathogenic variant in VPS37A

AU - Mealy, Maureen A.

AU - Nam, Tai Seung

AU - Pardo, Santiago J.

AU - Pardo-Villamizar, Carlos A

AU - Sobreira, Nara

AU - Avramopoulos, Dimitrios

AU - Valle, David

AU - Burns, Kathleen

AU - Levy, Michael

PY - 2018/2/1

Y1 - 2018/2/1

N2 - Objective: To identify genetic differences among siblings with a family history of idiopathic transverse myelitis (ITM). Methods: We compared whole-exome sequencing (WES) on germline samples from the 2 affected sisters with ITM with 3 of their healthy siblings. Results: The 2 sisters with ITM both had acute onset of sensory loss in the legs, weakness, and bowel/bladder dysfunction. The first developed ITM at age 15 years with a clinical nadir of complete paralysis, which slowly recovered over a few years. MRI demonstrated a persistent T2 lesion in the lower thoracic cord. The second developed ITM at age 50 years with a nadir of sensory loss from T6 down and paraparesis in the legs, associated with an MRI lesion at T6. She also made a partial recovery with treatment. Both sisters are homozygous for a missense variant in VPS37A (c.700C>A, p.Leu234Ile) identified by WES. We performed targeted sequencing of VPS37A in an additional 86 samples from patients with ITM and 175 with other diseases to investigate the p.Leu234Ile variant. We identified another patient with ITM homozygous for the same rare variant. No patients with multiple sclerosis, neuromyelitis optica, other neurologic conditions, or any healthy controls in public databases were homozygous for this variant. Conclusions: A rare missense variant in VPS37A may predispose to development of ITM. Further studies are necessary to determine the frequency of this variant in the patient population and the mechanism through which it contributes to the risk of disease.

AB - Objective: To identify genetic differences among siblings with a family history of idiopathic transverse myelitis (ITM). Methods: We compared whole-exome sequencing (WES) on germline samples from the 2 affected sisters with ITM with 3 of their healthy siblings. Results: The 2 sisters with ITM both had acute onset of sensory loss in the legs, weakness, and bowel/bladder dysfunction. The first developed ITM at age 15 years with a clinical nadir of complete paralysis, which slowly recovered over a few years. MRI demonstrated a persistent T2 lesion in the lower thoracic cord. The second developed ITM at age 50 years with a nadir of sensory loss from T6 down and paraparesis in the legs, associated with an MRI lesion at T6. She also made a partial recovery with treatment. Both sisters are homozygous for a missense variant in VPS37A (c.700C>A, p.Leu234Ile) identified by WES. We performed targeted sequencing of VPS37A in an additional 86 samples from patients with ITM and 175 with other diseases to investigate the p.Leu234Ile variant. We identified another patient with ITM homozygous for the same rare variant. No patients with multiple sclerosis, neuromyelitis optica, other neurologic conditions, or any healthy controls in public databases were homozygous for this variant. Conclusions: A rare missense variant in VPS37A may predispose to development of ITM. Further studies are necessary to determine the frequency of this variant in the patient population and the mechanism through which it contributes to the risk of disease.

UR - http://www.scopus.com/inward/record.url?scp=85048709403&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048709403&partnerID=8YFLogxK

U2 - 10.1212/NXG.0000000000000213

DO - 10.1212/NXG.0000000000000213

M3 - Article

C2 - 29473047

AN - SCOPUS:85048709403

VL - 4

JO - Neurology: Genetics

JF - Neurology: Genetics

SN - 2376-7839

IS - 1

M1 - e213

ER -